In summary, we found that miR-564 inhibited HCC proliferation, invasion and metastasis by targeting the GRB2-ERK1/2-AKT axis, thereby inhibiting the malignant phenotype of liver cancer. The gene discussed is GRB2; the disease is hepatocellular carcinoma.